Beskrivelse
Krav
Fullmektig i Norge:
Org.nummer: 925400262
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2009.06.29, US 221105 P
"Chapter 4.1" In: Steven A Frank: "Immnuology and Evolution of Infectious Disease", 2002, Princeton University Press, Princeton, NJ pages 35-36, (B1)
YUKO HORIKOSHI ET AL: "Development of A[beta] terminal end-specific antibodies and sensitive ELISA for A[beta] variant", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 319, no. 3, 1 July 2004 (2004-07-01), pages 733-737, XP55620547, AMSTERDAM, NL ISSN: 0006-291X, DOI: 10.1016/j.bbrc.2004.05.051 (B1)
CHRISTOPHER H. VAN DYCK: "Anti-Amyloid-[beta] Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise", BIOLOGICAL PSYCHIATRY, vol. 83, no. 4, 1 January 2018 (2018-01-01), pages 311-319, XP55446243, NEW YORK, NY; US ISSN: 0006-3223, DOI: 10.1016/j.biopsych.2017.08.010 (B1)
ENGLUND H ET AL: "Sensitive ELISA detection of amyloid-beta protofibrils in biological samples", JOURNAL OF NEUROCHEMISTRY, WILEY INTERSCIENCE, NEW YORK, NY, US, vol. 103, no. 1, 1 October 2007 (2007-10-01), pages 334-345, XP002688021, ISSN: 0022-3042, DOI: 10.1111/J.1471-4159.2007.04759.X [retrieved on 2007-06-09] (B1)
Gregory A Jicha: "Is passive immunization for Alzheimer's disease 'alive and well' or 'dead and buried'?", EXPERT OPINION ON BIOLOGICAL THERAPY, vol. 9, no. 4, 1 April 2009 (2009-04-01), pages 481-491, XP55446230, ASHLEY, LONDON; GB ISSN: 1471-2598, DOI: 10.1517/14712590902828285 (B1)
HUST MICHAEL ET AL: "Single chain Fab (scFab) fragment", BMC BIOTECHNOLOGY, BIOMED CENTRAL LTD. LONDON, GB, vol. 7, no. 1, 8 March 2007 (2007-03-08), page 14, XP021023594, ISSN: 1472-6750, DOI: 10.1186/1472-6750-7-14 (B1)
LORD A ET AL: "An amyloid-@b protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease", NEUROBIOLOGY OF DISEASE, ELSEVIER, AMSTERDAM, NL, vol. 36, no. 3, 1 December 2009 (2009-12-01), pages 425-434, XP026716877, ISSN: 0969-9961, DOI: 10.1016/J.NBD.2009.08.007 [retrieved on 2009-08-22] (B1)
Markus Morawski ET AL: "Glutaminyl cyclase in human cortex: correlation with (pGlu)-amyloid-[beta] load and cognitive decline in Alzheimer's disease", Journal of Alzheimer's disease : JAD, 1 January 2014 (2014-01-01), pages 385-400, XP55446158, Netherlands DOI: 10.3233/JAD-131535 Retrieved from the Internet: URL:https://content.iospress.com/download/ journal-of-alzheimers-disease/jad131535?id =journal-of-alzheimers-disease/jad131535 [retrieved on 2018-01-30] (B1)
SCHILLING STEPHAN ET AL: "Glutaminyl cyclase inhibition attenuates pyroglutamate A beta and Alzheimer's disease-like pathology", NATURE MEDICINE, NATURE PUB. CO, vol. 14, no. 10, 1 October 2008 (2008-10-01), pages 1106-1111, XP002559603, ISSN: 1078-8956, DOI: 10.1038/NM.1872 [retrieved on 2008-09-28] (B1)
US-A1- 2005 175 626 (B1)
US-B1- 7 122 374 (B1)
WO-A2-01/10900 (B1)
WO-A2-2004/013172 (B1)
WO-A2-2009/133521 (B1)
YOUSSEF I ET AL: "N-truncated amyloid-beta oligomers induce learning impairment and neuronal apoptosis" NEUROBIOLOGY OF AGING, TARRYTOWN, NY, US LNKD- DOI:10.1016/J.NEUROBIOLAGING.2007.03.005, vol. 29, no. 9, 1 September 2008 (2008-09-01), pages 1319-1333, XP022930369 ISSN: 0197-4580 [retrieved on 2008-07-16] (B1)
ACERO G ET AL: "Immunodominant epitope and properties of pyroglutamate-modified Abeta-specific antibodies produced in rabbits." JOURNAL OF NEUROIMMUNOLOGY 18 AUG 2009 LNKD- PUBMED:19545911, vol. 213, no. 1-2, 18 August 2009 (2009-08-18), pages 39-46, XP002605076 ISSN: 1872-8421 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP2448968)
|
Utgående
EP Registreringsbrev (3210) (PTEP2448968)
|
Innkommende, AR425979961
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 15. avg. år (EP) | 2024.05.21 | 6310 | Team Renewal | Betalt og godkjent |
Årsavgift 14. avg. år (EP) | 2023.05.30 | 4500 | Team Renewal | Betalt og godkjent |
Årsavgift 13. avg. år (EP) | 2022.05.20 | 4200 | Team Renewal | Betalt og godkjent |
Årsavgift 12. avg. år (EP) | 2021.05.21 | 3850 | Team Renewal | Betalt og godkjent |
32106182 expand_more expand_less | 2021.04.21 | 5580 | AWA NORWAY AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
Gebyr ved bruk av MasterCard-kort
80 = 80 X 1
|